Aimei Health Technology Co., Ltd
AFJK
$10.95
$0.000.00%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.30% | 101.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.30% | 101.24% | |||
| Operating Income | 35.30% | -101.24% | |||
| Income Before Tax | 22.07% | -19.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.07% | -19.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.07% | -19.38% | |||
| EBIT | 35.30% | -101.24% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 22.07% | -19.35% | |||
| Normalized Basic EPS | 22.04% | -19.31% | |||
| EPS Diluted | 22.07% | -19.35% | |||
| Normalized Diluted EPS | 22.04% | -19.31% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
